NPHS1基因突变致儿童局灶性节段性肾小球硬化1例报告并文献复习
NPHS1 Gene Mutations in Children with Focal Segmental Glomerulosclerosis and Literature Review
DOI: 10.12677/ACM.2024.142430, PDF,   
作者: 李玉婷:济南市妇幼保健院儿科,山东 济南;柏 翠, 郭兴青:青岛大学附属医院儿童医学中心,山东 青岛
关键词: 局灶节段性肾小球硬化NPHS1基因突变儿童Focal Segmental Glomerulosclerosis NPHS1 Gene Mutation Child
摘要: 目的:通过总结1例局灶性节段性肾小球硬化症(FSGS)患儿NPHS1基因突变的临床资料,提高对NPHS1突变表型的认识,探讨NPHS1基因突变与FSGS的关系。方法:收集1例FSGS患儿的病史、实验室检查及家族史。应用外显子检测(NGS)对儿童及其父母进行全外显子高通量测序。同时进行生物信息学分析。采用双脱氧链末端合成终止法测序对高通量测序结果进行验证,并进行相关文献复习。结果:患儿,女,7岁,6岁起病,确诊为肾病综合征,应用糖皮质激素尿蛋白一直未转阴,肾脏穿刺病理结果提示FSGS。家族史,患儿父亲患有肾病综合征,病理诊断为膜性肾病。测序结果NPHS1基因有c.803G > A错义突变(由父亲携带),和c.1339G > A、c.1802G > C错义突变(由母亲携带)。Mutationtaster软件预测的c.1339G > A、c.1802G > C为有害突变,c.803G > A突变存在多态性。c.1339G > A和c.1802G > C是NPHS1上由母亲携带的致病性突变,而c.803G > A突变目前未见报道。结论:NPHS1突变可引起儿童FSGS。突变c.803G > A可能是亚洲儿童新发突变,此突变进一步丰富了NPHS1基因谱。
Abstract: Objective: To summarize the clinical data of NPHSI gene mutation in a case of a child with focal seg-mental glomerulosclerosis (FSGS), to improve the understanding of NPHS1 mutation phenotype, to study the relationship between NPHSI gene mutation and FSGS. Method: Medical history, laboratory examination results and family history of a child with FSGS were collected. Exon detection (NGS) was applied to perform a full-exon high-throughout sequencing on the child and her parents. Mean-while, bioinformatics analysis was carried out. Sanger sequencing was used to verify the results of high-throughout sequencing, and relevant literature review was conducted. Result: The proband: female, 7 years old, onset on her age of six, developed nephrotic syndrome; result did not turn to be negative when Glucocorticoid uroprotein was applied; renal pathology indicated FSGS. Family sur-vey revealed that the father suffered nephrotic syndrome with a pathological diagnosis of mem-branous nephropathy. Sequencing found that the missense mutations of NPHS1 gene c.803G > A (carried by her father), c.1339G > A and c.1802G > C (carried by her mother) were found in child. The c.1339G > A, c.1802G > C, which were predicted by Mutationtaster software as harmful muta-tions, and c.803G > A mutation had polymorphism. The c.1339G > A and c.1802G > C, which have to be proven as a pathogenic mutationamutation carried by mother on NPHS1, while c.803G > A have not been reported at present. Conclusion: NPHS1 mutation can cause nephrotic syndrome with FSGS in children. Mutation c.803G > A is probably the newly discovered and further enriches the NPHS1 gene spectrum.
文章引用:李玉婷, 柏翠, 郭兴青. NPHS1基因突变致儿童局灶性节段性肾小球硬化1例报告并文献复习[J]. 临床医学进展, 2024, 14(2): 3037-3044. https://doi.org/10.12677/ACM.2024.142430

参考文献

[1] Rood, I.M., Deegens, J.K. and Wetzels, J.F. (2012) Genetic Causes of Focal Segmental Glomerulo-Sclerosis: Implica-tions for Clinical Practice. Nephrology Dialysis Transplantation, 27, 882-890. [Google Scholar] [CrossRef] [PubMed]
[2] Saleem, M.A. (2012) New Developments in Steroid-Resistant Nephrotic Syndrome. Journal of Pediatric Nephrology, 28, 699-709. [Google Scholar] [CrossRef] [PubMed]
[3] Pis-cione, T.D. and Licht, C. (2011) Genetics of Protein: An Overview of Gene Mutations Associated with Nonsyndromic Proteinuric Glomerulopathies. Advances in Chronic Kidney Disease, 18, 273-289. [Google Scholar] [CrossRef] [PubMed]
[4] 彭映潮, 高春林, 夏正坤. 儿童原发性局灶节段性肾小球硬化症治疗进展[J]. 临床儿科杂志, 2021, 39(8): 631-635.
[5] Sadowski, C.E., Lovric, S., Ashraf, S., et al. (2015) A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome. Journal of the American Society of Nephrology, 26, 1279-1289.
[6] Philippe, A., Nevo, F., Esquivel, E.L., et al. (2008) Nephrin Mutations Can Cause Child-Hood-Onset Steroid-Resistant Nephrotic Syndrome. Journal of the American Society of Nephrology, 19, 1871-1878. [Google Scholar] [CrossRef
[7] Bullich, G., Trujillano, D., Santín, S., et al. (2014) Targeted Next-Generation Sequencing in Steroid Resistant Nephrotic Syndrome: Mutations in Multiple Glomerular Genes May Influence Disease Severity. European Journal of Human Genetics, 23, 1192-1199. [Google Scholar] [CrossRef] [PubMed]
[8] Shabaka, A., Tato Ribera, A. and Fernández-Juárez, G. (2020) Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective. Nephron, 144, 413-427. [Google Scholar] [CrossRef] [PubMed]
[9] Xu, P., Zou, Y., Li, J., et al. (2016) Identification of a Novel Splicing Mutation of PKD1 Gene in a Pedigree Affected with Autosomal Dominant Polycystic Kidney Disease. Chinese Journal of Medical Genetics, 33, 778-781.
[10] Gast, C., Pengelly, R.J., Lyon, M., et al. (2016) Collagen (COL4A) Mutations Are the Most Frequent Mutations Underlying Adult Focal Segmental Domemlosclerosis. Nephrology Dialysis Trans-plantation, 31, 961-970. [Google Scholar] [CrossRef] [PubMed]
[11] Büscher, A.K., Kranz, B., Büscher, R., et al. (2010) Immunosuppression and Renal Outcome in Congenital and Pediatric Steroid-Resistant Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology, 5, 2075-2084. [Google Scholar] [CrossRef
[12] Cheong, H.I. (2020) Genetic Tests in Children with Steroid-Resistant Nephrotic Syndrome. Kidney Research and Clinical Practice, 39, 7-16. [Google Scholar] [CrossRef] [PubMed]
[13] Sharif, B. and Barua, M. (2018) Advances in Molecular Diagnosis and Therapeutics in Nephrotic Syndrome and Focal and Segmental Glomerulosclerosis. Current Opinion in Nephrology and Hypertension, 27, 1-9. [Google Scholar] [CrossRef
[14] 陈丽颖, 李志鑫, 饶睿, 等. 先天性肾病综合征1例报告及文献复习[J]. 医学理论与实践, 2021, 34(6): 1012-1014.
[15] 赵锋. 肾综患儿的激素治疗和基因诊断[J]. 家庭医学(下半月), 2021(3): 24-25.
[16] Serramontmany, E., Muñoz, M., Fernández-Polo, A., Morillo, M., Gómez-Ganda, L., Cañete-Ramírez, C. and Ariceta, G. (2021) Home Albumin Infusion Therapy, Another Alternative Treatment in Patients with Congenital Nephrotic Syndrome of the Finnish Type. Frontiers in Pediatrics, 8, Article ID: 614535. [Google Scholar] [CrossRef] [PubMed]
[17] Thomas, M.M., Ahmed, H.M., El-Dessouky, S.H., Ramadan, A., Botrous, O.E. and Abdel-Hamid, M.S. (2022) Spectrum of NPHS1 and NPHS2 Variants in Egyptian Children with Fo-cal Segmental Glomerular Sclerosis: Identification of Six Novel Variants and Founder Effect. Molecular Genetics and Genomics, 297, 689-698. [Google Scholar] [CrossRef] [PubMed]
[18] Caridi, G., Gigante, M., Ravani, P., et al. (2009) Clinical Fea-tures and Long-Term Outcome of Nephrotic Syndrome Associated with Heterozygous NPHS1 and NPHS2 Mutations. Clinical Journal of the American Society of Nephrology, 4, 1065-1072. [Google Scholar] [CrossRef